Roxadustat inhibits HIF prolyl hydroxylase enzymes (HIF-PH), preventing the degradation of hypoxia-inducible factor (HIF) transcription factors. This increases HIF activity, leading to:
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Renesis 50 (Roxadustat) is the first-in-class orally administered hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI). It promotes erythropoiesis by:
Renesis 50 is indicated for the treatment of symptomatic anemia in adult patients associated with chronic kidney disease (CKD).
Roxadustat should be taken three times per week, ensuring non-consecutive days, and the dose must be tailored to achieve and maintain hemoglobin (Hb) levels between 10–12 g/dL.
Follow this progression for dose adjustments (up or down):
20 mg → 40 mg → 50 mg → 70 mg → 100 mg → 150 mg → 200 mg → 250 mg → 300 mg → 400 mg (for dialysis patients only).
Do not administer to women that may be pregnant or pregnant. Roxadustat is contraindicated during breast-feeding.
Phosphate Binders or Multivalent Cation-Containing Products:
Gemfibrozil or Probenecid:
Statins (Simvastatin, Rosuvastatin, Atorvastatin):
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.